Orchestra BioMed Holdings, Inc. (OBIO) Gross profit 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual gross profit history from SEC filings — each fiscal year as reported.
$33.3MFY2025 · since FY2022: $3.3M → $33.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $33.3M | +1267.8% |
| FY2024 | $2.4M | -5.4% |
| FY2023 | $2.6M | -22.5% |
| FY2022 | $3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Net marginOBIO Gross marginOBIO Operating incomeOBIO Operating marginOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →